Insights On Trial Design
-
A Comparative Guide To CGTs: Modalities, Landscape, And Logistics
2/29/2024
Cell and gene therapies (CGTs) have the potential to revolutionize medicine. However, achieving therapeutic success requires advanced logistical consideration to ensure product safety and efficacy
-
Revolutionizing Clinical Trial Feasibility
1/13/2025
Transform feasibility into a continuous, data-driven process, that helps sponsors streamline trial planning, maintain timelines, and deliver therapies to patients faster.
-
2023 Technology Adoption Trends And Plateaus
11/15/2023
About 85% of industry leaders and managers have had some exposure to AI. Delve into the state of AI adoption experienced throughout 2023 and where the industry is headed concerning digital tool usage.
-
Multi-Regional Clinical Trials: The Latest Guidance From FDA
3/12/2025
Conducting multi-regional clinical trials (MRCTs) is essential for accelerating oncology drug development and ensuring broader patient access. However, differences across regions can impact findings.
-
Chronic Lymphocytic Leukemia: Global Clinical Trial Landscape (2024)
8/19/2024
CLL is slow-progressing leukemia primarily affecting older adults. Get the latest information on research, innovative therapies, and emerging clinical trials shaping CLL care by downloading this report.
-
7 Essential Steps On The Promising Path Of Psychedelic Therapy
9/26/2023
Understand why it is imperative to reevaluate and transform mental health treatment, offering individuals the effective and comprehensive care they so desperately require—and how to do it.
-
Planning For Complex Change At Your Organization
5/15/2024
With technology advancing clinical operations, proactive adaptation is paramount for organizations to remain at the forefront. How can your organization effectively navigate these evolving dynamics?
-
Public Perceptions Of Clinical Trials: A Comprehensive Survey
9/20/2023
To gain insight into the public's general perceptions and understanding of clinical research, review the findings from this survey, which encompassed 1,000 randomly selected U.S. residents.
-
The Final DCT Guidance: I'm Not Mad At It
12/13/2024
Explore the FDA's 2024 final guidance on DCTs, including key updates that address previous concerns, affecting healthcare providers, sub-investigators, and sponsors.
-
Cross-Border M&A: 10 Key Trends To Watch In 2023
4/17/2023
Many observers believe deal volume will remain buoyant throughout 2023. The need for access to cash is expected to continue to drive M&A decision-making. Heightened regulatory scrutiny, supply chain weakness, and consolidation are a few of the trends to watch for the remainder of the year.